Gilead Sciences to Present at Upcoming Investor Engagements

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• Jefferies London Healthcare Conference on Wednesday, November 20 at 9:30 AM Greenwich Mean Time
• Piper Sandler Annual Healthcare Conference on Tuesday, December 3 at 11:00 AM Eastern Time
• Annual Evercore ISI HealthCONx Conference on Wednesday, December 4 at 11:40 AM Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241108042891/en/

Jacquie Ross, CFA – Investors
[email protected]

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
• Fernandina Beach Exterior Cleaning Expands Comprehensive Maintenance Programs to Address Coastal Property Wear in Northeast Florida
• Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2025/2026 financial year